You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

clinical endpoints

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Structure and Clinical Endpoints in Myotonic Dystrophy

Recruiting
  • Myotonic Dystrophy Type 2
  • Non-interventional study
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
May 2, 2023

Herbal Interaction Trial in Spokane (Kratom, Oxycodone)

Not yet recruiting
  • Herbal Interaction
  • Spokane, Washington
    Washington State University College of Pharmacy and Pharmaceutic
Apr 26, 2023

Ulcerative Colitis Trial (2'-Fucosyllactose, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • 2'-Fucosyllactose
  • Placebo
  • (no location specified)
Sep 26, 2023

Predictor of Clinical Endpoints in Pediatric Autoimmune Liver

Recruiting
  • Autoimmune Liver Disease
  • +2 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital and Medical Center
    Feb 7, 2022

    Creatine Transporter Defect Trial in Bron (Clinical endpoints, Parental questionnaires, Quality of life scale)

    Recruiting
    • Creatine Transporter Defect
    • Clinical endpoints
    • +9 more
    • Bron, France
      Woman, mother and child hospital, Hospices Civils de Lyon
    Aug 25, 2023

    Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)

    Terminated
    • Myotonic Dystrophy Type-1
    • Myotonic Dystrophy Type-2
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Nov 2, 2021

      Idiopathic Parkinson Disease Trial in Petach Tikva (NeuraLight software-based platform)

      Recruiting
      • Idiopathic Parkinson Disease
      • NeuraLight software-based platform
      • Petach Tikva, Israel
        Rabin Medical Center
      Aug 14, 2022

      Primary Sjögren's Syndrome (pSS) Trial in Le Kremlin-Bicêtre (Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate

      Recruiting
      • Primary Sjögren's Syndrome (pSS)
      • Hydroxychloroquine 400mg/d
      • +5 more
      • Le Kremlin-Bicêtre, France
        Raphaele Seror
      May 2, 2022

      Study to Evaluate the Risk of Cardiovascular Endpoints

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Aclidinium bromide
      • Other COPD medication
      • London, United Kingdom
        Clinical Practice Research Datalink
      Jan 30, 2023

      Clinical Endpoints in ALS Patients

      Recruiting
      • Amyotrophic Lateral Sclerosis
      • NeuraLight software-based platform
      • Tel Aviv, Israel
        Sourasky medical center
      Jun 2, 2022

      Development of Novel Clinical Endpoints in Intermediate AMD

      Active, not recruiting
      • Age Related Macular Degeneration (AMD)
      • No intervention
      • Copenhagen, Denmark
      • +19 more
      May 23, 2022

      Alzheimer's Disease With Vascular Pathology Trial in United States (CY6463, Placebo)

      Recruiting
      • Alzheimer's Disease With Vascular Pathology
      • Scottsdale, Arizona
      • +4 more
      Jun 9, 2022

      Hearing Loss Trial in Lone Tree, Melbourne (the Mobile Research App, SOC/validated delivery of the speech perception test

      Not yet recruiting
      • Hearing Loss
      • the Mobile Research App
      • SOC/validated delivery of the speech perception test material
      • Lone Tree, Colorado
      • +1 more
      Oct 19, 2023

      Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

      Recruiting
      • Myotonic Dystrophy 1
        • Stanford, California
        • +15 more
        Dec 8, 2021

        Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy

        Recruiting
        • Limb Girdle Muscular Dystrophy
        • Muscular Dystrophies
          • Irvine, California
          • +10 more
          Sep 13, 2021

          Pneumoperitoneum Trial in New York (Cold and dry CO2 pneumoperitoneum, Warm and humidified CO2 pneumoperitoneum)

          Not yet recruiting
          • Pneumoperitoneum
          • Cold and dry CO2 pneumoperitoneum
          • Warm and humidified CO2 pneumoperitoneum
          • New York, New York
            Mount Sinai West Hospital
          Jan 18, 2022

          Alzheimer Trial in United States (ACU193, Placebo)

          Active, not recruiting
          • Alzheimer Disease
          • Scottsdale, Arizona
          • +16 more
          Feb 1, 2023

          Best Clinical Endpoints That Likely Induce Worse Prognosis in

          Recruiting
          • Interstitial Lung Disease
          • Daily physical activity levels
          • +14 more
          • Londrina, Paraná, Brazil
            Universidade Estadual de Londrina
          Jul 26, 2021

          Alzheimer Trial in United States (NE3107, Placebo)

          Recruiting
          • Alzheimer Disease
          • Scottsdale, Arizona
          • +32 more
          Jul 8, 2022

          Metabolic Syndrome, Overweight Trial in Columbus (wheat-safflower oil pretzels, soy-safflower oil pretzels, control wheat

          Active, not recruiting
          • Metabolic Syndrome
          • Overweight
          • wheat-safflower oil pretzels
          • +2 more
          • Columbus, Ohio
            The Ohio State University Wexner Medical Center Clinical Researc
          Sep 23, 2021

          Variability of Definitions for Survival Endpoints and Surrogate

          Completed
          Has Results
          • Cancer
          • (no location specified)
          Dec 30, 2020

          (PASS) in the European Union (EU)

          Completed
          Has Results
          • Osteoporosis, Postmenopausal
          • (no location specified)
          Apr 27, 2020

          Bioequivalence, Asthma Trial in Larissa (Test, Reference)

          Active, not recruiting
          • Bioequivalence
          • Asthma
          • Larissa, Thessaly, Greece
            BECRO Clinical Facility
          Oct 19, 2021

          Mild to Moderate Alzheimer's Disease Trial in Australia, United States (CT1812, Placebo)

          Recruiting
          • Mild to Moderate Alzheimer's Disease
          • Phoenix, Arizona
          • +18 more
          Aug 16, 2022

          Essential Tremor Trial in Germany, Poland, United States (JZP385, Placebo)

          Recruiting
          • Essential Tremor
          • Birmingham, Alabama
          • +50 more
          Jan 18, 2023